Because RAB31 plays an oncogenic role in a variety of human cancers, interventions targeting RAB31 expression may aid in inhibiting the progression of GC, and using RAB31-targeted miRNAs may provide a promising method for GC treatment. The gene discussed is RAB31; the disease is gastric cancer.